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Background
Brd4 (bromodomain-containing protein 4) is an important
epigenetic reader that plays a crucial role in cellular prolif-
eration and cell cycle progression. Several recent studies
have identified Brd4 as a critical therapeutic target in a
number of different cancers. Brd4 is also an important tar-
get of several oncogenic viruses and the translocation t
(15;19) that accounts for a highly aggressive carcinoma.
The t(15;19) translocation results in the novel in-frame
fusion of the Brd4 N-terminal component with almost the
entire sequence of Nut (Nuclear protein in testis) mole-
cule, leading to the formation of a novel fusion oncogene,
Brd4-Nut. The mechanism by which the Brd4-Nut fusion
product contributes to oncogenesis remains to be clearly
defined.
Materials and methods
In this study, we combined an array of complementary
techniques to examine the Brd4 function in chromatin
structure maintenance. Using the t(15;19) cancer cell line
HCC2429 established from an aggressive, metastatic lung
cancer arising in a woman demonstrating a t(15;19), we
also performed mechanistic studies to characterize the
functional differences between the Brd4-Nut oncoprotein
and the native Brd4 isoforms. This study investigated how
the Brd4-Nut cancer-predisposing genetic mutation abro-
gates Brd4 cellular function to contribute to oncogenic
progression.
Results
We applied in situ single cell chromatin imaging and
micro-coccal nuclease (MNase) assay to show that Brd4
depletion leads to a large scale chromatin unfolding,
while a dominant negative inhibitor encoding the double
bromodomain (BDI/II) of Brd4 can competitively dis-
sociate endogenous Brd4 from chromatin to trigger
severely fragmented chromatin morphology. Using the
bimolecular fluorescence complementation (BiFC) tech-
nology, we demonstrated that Brd4 molecules interact
intermolecularly on chromatin to provide a molecular
scaffold for maintaining nucleosomes in a properly orga-
nized chromatin conformation. In the t(15;19) HCC2429
cancer cells, Brd4-Nut localizes to discrete nuclear foci
and recruits histone acetyltransferases (HATs) to induce
histone hyperacetylation, leading to sequestration of
Brd4 in these chromatin foci. Using immunofluorescent
microscopy and biochemical analysis, we showed that
this Brd4-Nut activity significantly enhances Brd4 asso-
ciation with chromatin in HCC2429 cells. Interestingly,
exogenous expression of Brd4-Nut in cells without this
oncogenic mutation also triggered a tighter Brd4 binding
to chromatin. The Brd4-Nut induced Brd4 chromatin
sequestration promotes expression of a number of Brd4
downstream target genes, which are important for cell
cycle regulation, cellular proliferation and transforma-
tion. Brd4-Nut knockdown in HCC2429 cells abrogates
HAT recruitment and disperses the histone hyperacety-
lated chromatin foci, leading to inactivation of Brd4
downstream target genes and inhibition of cellular
transformation.
Conclusions
Our studies demonstrate that Brd4 binding to chromatin
is essential for maintaining a properly organized chroma-
tin conformation. We also investigated the structural and
functional consequences associated with the t(15;19)-
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revealed additional mechanisms by which this oncogenic
mutation perturbs Brd4 function to cause epigenetic
reprogramming and malignant progression in the highly
aggressive t(15;19) cancers.
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